ALXN
Connor, Clark & Lunn Investment Management (CC&L)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,842
| Closed | -$1.81M | – | 1277 |
|
|
2021
Q2 | $1.81M | Sell |
9,842
-2,708
| -22% | -$497K | 0.01% | 562 |
|
|
2021
Q1 | $1.92M | Buy |
12,550
+596
| +5% | +$91.1K | 0.01% | 568 |
|
|
2020
Q4 | $1.87M | Buy |
+11,954
| New | +$1.87M | 0.01% | 523 |
|
|
2020
Q3 | – | Sell |
-8,742
| Closed | -$981K | – | 1187 |
|
|
2020
Q2 | $981K | Sell |
8,742
-116,568
| -93% | -$13.1M | 0.01% | 618 |
|
|
2020
Q1 | $11.3M | Sell |
125,310
-113,405
| -48% | -$10.2M | 0.1% | 142 |
|
|
2019
Q4 | $25.8M | Buy |
238,715
+133,475
| +127% | +$14.4M | 0.18% | 101 |
|
|
2019
Q3 | $10.3M | Buy |
105,240
+77,175
| +275% | +$7.56M | 0.07% | 172 |
|
|
2019
Q2 | $3.68M | Buy |
28,065
+23,850
| +566% | +$3.12M | 0.02% | 336 |
|
|
2019
Q1 | $570K | Buy |
4,215
+575
| +16% | +$77.8K | ﹤0.01% | 644 |
|
|
2018
Q4 | $354K | Sell |
3,640
-36,768
| -91% | -$3.58M | ﹤0.01% | 770 |
|
|
2018
Q3 | $5.62M | Sell |
40,408
-69,475
| -63% | -$9.66M | 0.03% | 299 |
|
|
2018
Q2 | $13.6M | Sell |
109,883
-105,475
| -49% | -$13.1M | 0.08% | 182 |
|
|
2018
Q1 | $24M | Buy |
215,358
+21,858
| +11% | +$2.44M | 0.15% | 120 |
|
|
2017
Q4 | $23.1M | Buy |
193,500
+87,550
| +83% | +$10.5M | 0.14% | 130 |
|
|
2017
Q3 | $14.9M | Buy |
105,950
+62,275
| +143% | +$8.74M | 0.09% | 155 |
|
|
2017
Q2 | $5.31M | Buy |
43,675
+40,975
| +1,518% | +$4.99M | 0.03% | 263 |
|
|
2017
Q1 | $327K | Sell |
2,700
-3,500
| -56% | -$424K | ﹤0.01% | 713 |
|
|
2016
Q4 | $759K | Buy |
6,200
+2,100
| +51% | +$257K | 0.01% | 534 |
|
|
2016
Q3 | $502K | Sell |
4,100
-3,600
| -47% | -$441K | ﹤0.01% | 580 |
|
|
2016
Q2 | $899K | Sell |
7,700
-7,600
| -50% | -$887K | 0.01% | 486 |
|
|
2016
Q1 | $2.13M | Sell |
15,300
-18,575
| -55% | -$2.59M | 0.02% | 325 |
|
|
2015
Q4 | $6.46M | Sell |
33,875
-21,725
| -39% | -$4.14M | 0.05% | 185 |
|
|
2015
Q3 | $8.7M | Buy |
+55,600
| New | +$8.7M | 0.07% | 139 |
|
|
2014
Q2 | – | Sell |
-2,053
| Closed | -$345K | – | 664 |
|
|
2014
Q1 | $345K | Sell |
2,053
-5,000
| -71% | -$840K | ﹤0.01% | 545 |
|
|
2013
Q4 | $996K | Buy |
+7,053
| New | +$996K | 0.01% | 369 |
|